arrow
H

Haiying Qin

nih national cancer institute (nci)
H指数:28
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma
2022-08-1542
OAAI
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

CD19和CD22双重靶向CAR T细胞治疗复发性或难治性b细胞恶性肿瘤的1期临床试验

2021-07-26360
OAAI
Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients

穿孔素缺陷型CAR T细胞重述在患者中观察到的迟发性炎症毒性

2020-09-1444
OA
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
2017-11-201.1K
OAAI